Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: data from the national health and nutrition examination survey (NHANES).

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Environmental Science and Technology

• Publication date

  2007-03-06

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1021/ES062686MPMID 17438769
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Community Exposure to Perfluorooctanoate: Relationships Between Serum Levels and Certain Health Parameters

  2006cited by this paper
• Perfluorochemicals in pooled serum samples from United States residents in 2001 and 2002.

  2006cited by this paper
• Pilot study on the perfluorooctanesulfonate and perfluorooctanoate exposure of the German general population.

  2006cited by this paper
• Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys--probing the determinants of long plasma half-lives.

  2006cited by this paper
• Biological monitoring of polyfluoroalkyl substances: A review.

  2006cited by this paper
• Perfluorooctanesulfonate and related fluorochemicals in human blood samples from China.

  2006cited by this paper
• Measurement of 18 perfluorinated organic acids and amides in human serum using on-line solid-phase extraction.

  2005cited by this paper
• Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion.

  2005cited by this paper
• Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries.

  2004cited by this paper
• Perfluorooctane Sulfonate (PFOS) and Related Perfluorinated Compounds in Human Maternal and Cord Blood Samples: Assessment of PFOS Exposure in a Susceptible Population during Pregnancy

  2004cited by this paper
• The Toxicology of Perfluorooctanoate

  2004cited by this paper
• The Influence of Time, Sex and Geographic Factors on Levels of Perfluorooctane Sulfonate and Perfluorooctanoate in Human Serum over the Last 25 years

  2004cited by this paper
• The developmental toxicity of perfluoroalkyl acids and their derivatives.

  2004cited by this paper
• Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington.

  2004cited by this paper
• Analysis of Episodes of Care in a Perfluorooctanesulfonyl Fluoride Production Facility

  2004cited by this paper
• A survey of perfluorooctane sulfonate and related perfluorinated organic compounds in water, fish, birds, and humans from Japan.

  2003cited by this paper
• Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors.

  2003cited by this paper
• Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility

  2003cited by this paper
• Mortality among employees of a perfluorooctanoic acid production plant.

  1993cited by this paper

• PFOS exposure at environmentally relevant concentrations promote papillary thyroid carcinoma progression through PI3K/AKT/mTOR-mediated epithelial-mesenchymal transition.

  2026cites this paper
• Residential proximity to transport facilities as urban determinants of individual-level per- and poly-fluoroalkyl substance (PFAS) exposures: Analysis of two longitudinal cohorts in Singapore.

  2026cites this paper
• The role of per‐ and polyfluoroalkyl substances in cognitive impairment and dementia

  2025cites this paper
• Human gut bacteria bioaccumulate per- and polyfluoroalkyl substances

  2025cites this paper
• Per- and polyfluoroalkyl substance concentrations during pregnancy and at birth and risk of childhood acute lymphoblastic leukemia.

  2025cites this paper
• Biomonitoring result of PFAS exposure from Gabreski Air National Firefighting foam among residents in Westhampton, NY

  2025cites this paper
• Assessment of PFAS levels in drinking water: A case study from Poznań County (Poland).

  2025cites this paper
• Human liver perfluorooctane sulfonate associates with steatotic liver disease in a sex-dependent manner.

  2025cites this paper
• Impact of Per- and Polyfluoroalkyl Substances Exposure on Renal Dysfunction: Integrating Epidemiological Evidence with Mechanistic Insights.

  2025cites this paper
• Perfluorooctanoic Acid and Its Short-Chain Substitutes Induce Cytotoxic and Prooxidative Changes in Human Peripheral Blood Mononuclear Cells: A Comparative Study

  2025influential citation
• Performance of pressure stimuli-responsive nanofiltration and cellulose acetate forward osmosis membranes for PFOA contaminated wastewater treatment

  2025cites this paper
• Circulating per- and polyfluoroalkyl substances and risk of pancreatic cancer: a nested case-control study within the NYU Women's Health Study.

  2025cites this paper
• Adolescent Bone Health Under Threat: PFAS Mixtures as Drivers of Skeletal Fragility

  2025cites this paper
• Prenatal PFAS exposure and outcomes related to maternal gut microbiome composition in later pregnancy.

  2025cites this paper
• Supporting informed decisions about breast cancer screening in communities with known environmental contamination: a pre-post study

  2025cites this paper
• Perfluorinated chemicals and adolescent respiratory health: Epidemiological evidence and mechanistic insights

  2025cites this paper
• Degree of food processing and serum poly- and perfluoroalkyl substance concentrations in the US National Health and Nutrition Examination Survey, 2003-2018.

  2025cites this paper
• Levels of serum per- and polyfluoroalkyl substances and association with dyslipidemia in the Korean population.

  2025cites this paper
• Assessment of per- and polyfluoroalkyl substances (PFAS) exposure and associations with oxidative stress biomarkers among pregnant women from the PROTECT cohort.

  2025cites this paper
• Per- and Polyfluoroalkyl Substances (PFAS) Exposure in the U.S. Population: NHANES 1999-March 2020.

  2025cites this paper
• In vivo gamete toxicology in the context of in vitro fertilization: a narrative review.

  2025cites this paper
• Serum concentrations of per- and polyfluoroalkyl substances and risk of ovarian cancer.

  2025cites this paper
• Extracellular Vesicle (EV) Mechanisms of Toxicity for Per and Polyfluoroalkyl Substances: Comparing Transcriptomic Points of Departure Across Global Versus EV Regulatory Gene Sets

  2025cites this paper
• Short-chain per- and polyfluoroalkyl substances associate with elevated alanine aminotransferase: Cross-sectional analysis results from the STRIVE cohort.

  2025cites this paper
• 6:2 fluorotelomer sulfonate as a safer alternative to PFOS: Comparative cytotoxicity and oxidative stress mechanisms in pancreatic β-cells (INS-1 model).

  2025cites this paper
• Maternal factors associated with plasma concentrations of endocrine-disrupting persistent organic pollutants including PFAS among Hispanic women from pregnancy to the post-delivery period

  2025cites this paper
• Per- and Polyfluoroalkyl Substances and Female Health Concern: Gender-based Accumulation Differences, Adverse Outcomes, and Mechanisms.

  2025cites this paper
• Prenatal PFAS exposure associates with DXA assessed markers of adiposity in 7-year-old children from the Odense Child Cohort.

  2025cites this paper
• Human biomonitoring follow-up study on PFOA contamination and investigation of possible influencing factors on PFOA exposure in a German population originally exposed to emissions from a fluoropolymer production plant.

  2024cites this paper
• Per- and polyfluoroalkyl substances (PFAS) in paired tap water and house dust from United States homes

  2024cites this paper
• Associations of dietary intake and longitudinal measures of per- and polyfluoroalkyl substances (PFAS) in predominantly Hispanic young Adults: A multicohort study

  2024cites this paper
• Effect of liver cancer on the accumulation and hepatobiliary transport of per- and polyfluoroalkyl substances.

  2024cites this paper
• Per- and polyfluoroalkyl ether acids in well water and blood serum from private well users residing by a fluorochemical facility near Fayetteville, North Carolina

  2024cites this paper
• General toxicity and screening of reproductive and developmental toxicity following bioaccumulation of oral-dosed perfluorooctanoic acid: Loss of the Golgi apparatus.

  2024cites this paper
• Interaction of Per- and Polyfluoroalkyl Substances with Estrogen Receptors in Rainbow Trout (Oncorhynchus mykiss): An In Silico Investigation

  2024cites this paper
• Perfluorooctanoate (PFOA) cell-autonomously promotes thermogenic and adipogenic differentiation of brown and white adipocytes.

  2024cites this paper
• Off-purpose activity of industrial and agricultural chemicals against human gut bacteria

  2024cites this paper
• Increasing disparities in human exposure to perfluorooctanesulfonic acid: Findings from per- and polyfluoroalkyl substance concentrations in 1999–2018 NHANES

  2024cites this paper
• Environmental Exposure to Per- and Polyfluorylalkyl Substances (PFASs) and Reproductive Outcomes in the General Population: A Systematic Review of Epidemiological Studies

  2024influential citation
• Association of Vitamin D with Perfluorinated Alkyl Acids in Women with and without Non-Obese Polycystic Ovary Syndrome

  2024cites this paper
• Reliability of toxicokinetic modelling for PFAS exposure assessment in contaminated water in northern Italy

  2024cites this paper
• Initial demonstration of microplasma ionization/Orbitrap mass spectrometry for molecular screening of perfluorinated compounds

  2024cites this paper
• Associations between serum per- and polyfluoroalkyl substances and thyroid hormones in Chinese adults: A nationally representative cross-sectional study.

  2024cites this paper
• Direct measurement of PFAS levels in surface water using an engineered biosensor

  2024cites this paper
• Association between perfluoroalkyl and polyfluoroalkyl internal exposure and serum α-Klotho levels in middle-old aged participants

  2023cites this paper
• Unraveling the mechanisms of perfluorooctanesulfonic acid-induced dopaminergic neurotoxicity and microglial activation in developing zebrafish.

  2023cites this paper
• Plasma concentrations of per- and polyfluoroalkyl substances are associated with perturbations in lipid and amino acid metabolism.

  2023cites this paper
• Maternal per- and poly-fluoroalkyl substances exposure and child adiposity measures: A birth cohort study.

  2023cites this paper
• Perfluorooctanoic acid (PFOA) and hexafluoropropylene oxide-dimer acid (GenX): Hepatic stress and bile acid metabolism with different pathways.

  2023cites this paper
• Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.

  2023cites this paper
• Maternal serum concentrations of per- and polyfluoroalkyl substances and childhood acute lymphoblastic leukemia.

  2023cites this paper
• PFOA/PFOS Facilitated Intestinal Fatty Acid Absorption by Activating the PPARα Pathway: Insights from Organoids Model

  2023cites this paper
• Geographic and demographic variability in serum PFAS concentrations for pregnant women in the United States

  2023cites this paper
• Endocrine Disruptors and Thyroid Health.

  2023cites this paper
• Case–Cohort Study of the Association between PFAS and Selected Cancers among Participants in the American Cancer Society’s Cancer Prevention Study II LifeLink Cohort

  2023cites this paper
• Emerging environmental health risks associated with the land application of biosolids: a scoping review

  2023cites this paper
• PFAS concentrations in early and mid-pregnancy and risk of gestational diabetes mellitus in a nested case-control study within the ethnically and racially diverse PETALS cohort

  2023cites this paper
• Elevated Maternal Testosterone Levels Alter PFOA Elimination and Tissue Distribution in Pregnant Rats.

  2023influential citation
• A genetically-encoded biosensor for direct detection of perfluorooctanoic acid

  2023cites this paper
• PFAS levels in paired drinking water and serum samples collected from an exposed community in Central North Carolina.

  2023cites this paper
• Per- and polyfluoroalkyl substances and the associated thyroid cancer risk: A case-control study in China.

  2023cites this paper
• A prospective nested case-control study of serum concentrations of per- and polyfluoroalkyl substances and aggressive prostate cancer risk.

  2023cites this paper
• Association of per- and polyfluoroalkyl substances with hepatic steatosis and metabolic dysfunction-associated fatty liver disease among patients with acute coronary syndrome.

  2023cites this paper
• The interference between effects of PFAS exposure on thyroid hormone disorders and cholesterol levels: an NHANES analysis

  2023cites this paper
• Association between perfluoroalkyl substances concentration and bone mineral density in the US adolescents aged 12-19 years in NHANES 2005-2010

  2022cites this paper
• PFAS levels and exposure determinants in sensitive population groups.

  2022cites this paper
• Photodynamic Priming Overcomes Per‐ and Polyfluoroalkyl Substance (PFAS)‐Induced Platinum Resistance in Ovarian Cancer†

  2022cites this paper
• Green Extraction Processes for Complex Samples from Vegetable Matrices Coupled with On-Line Detection System: A Critical Review

  2022cites this paper
• Serum per- and polyfluoroalkyl substance concentrations in four municipal US fire departments.

  2022cites this paper
• Association of increased risk of cardiovascular diseases with higher levels of perfluoroalkylated substances in the serum of adults

  2022cites this paper
• Perfluorooctanoic Acid Affects Mouse Brain and Liver Tissue Through Oxidative Stress

  2022cites this paper
• The Role of Fecal Microbiota in Liver Toxicity Induced by Perfluorooctane Sulfonate in Male and Female Mice

  2022cites this paper
• Risk assessment for PFOA and kidney cancer based on a pooled analysis of two studies.

  2022cites this paper
• Evaluating maternal exposure to an environmental per and polyfluoroalkyl substances (PFAS) mixture during pregnancy: Adverse maternal and fetoplacental effects in a New Zealand White (NZW) rabbit model.

  2022cites this paper
• The relationship between multiple perfluoroalkyl substances and cardiorespiratory fitness in male adolescents

  2022cites this paper
• Association Between Exposure to Per- and Polyfluoroalkyl Substances and Birth Outcomes: A Systematic Review and Meta-Analysis

  2022cites this paper
• An Epidemiologic Review of Menstrual Blood Loss as an Excretion Route for Per- and Polyfluoroalkyl Substances

  2022cites this paper
• Exposure to Per- and Polyfluoroalkyl Substances and Body Composition in US Adolescents Aged 12-18 years: an analysis of data from the National Health and Nutrition Examination Surveys 2011-2018

  2022cites this paper
• Association between per- and polyfluoroalkyl substances exposure and risk of diabetes: a systematic review and meta-analysis

  2022cites this paper
• Demographic, life-style and physiological determinants of serum per- and polyfluoroalkyl substance (PFAS) concentrations in a national cross-sectional survey of Swedish adolescents.

  2022cites this paper
• Concentrations of per- and polyfluoroalkyl substances (PFAS) in human placental tissues and associations with birth outcomes.

  2022cites this paper
• A novel procedure for predicting chronic toxicities and ecological risks of perfluorinated compounds in aquatic environment.

  2022cites this paper
• Human exposure pathways to poly- and perfluoroalkyl substances (PFAS) from indoor media: A systematic review

  2022cites this paper
• Engineering human liver fatty acid binding protein for detection of poly‐ and perfluoroalkyl substances

  2021cites this paper
• Latent, sex-specific metabolic health effects in CD-1 mouse offspring exposed to PFOA or HFPO-DA (GenX) during gestation

  2021cites this paper
• Per- and polyfluoroalkyl substances exposure and bone mineral density in the U.S. population from NHANES 2005–2014

  2021cites this paper
• Exposure to perfluoroalkyl substances in waste recycling workers: Distributions in paired human serum and urine.

  2021cites this paper
• Associations of exposure to perfluoroalkyl substances individually and in mixtures with persistent infections: Recent findings from NHANES 1999-2016.

  2021cites this paper
• Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.

  2021cites this paper
• Per- and polyfluoroalkyl substances and kidney function: Follow-up results from the Diabetes Prevention Program trial.

  2021cites this paper
• Regulating PFAS as a Chemical Class under the California Safer Consumer Products Program

  2021cites this paper
• Developmental exposures to perfluorooctanesulfonic acid (PFOS) impact embryonic nutrition, pancreatic morphology, and adiposity in the zebrafish, Danio rerio.

  2021influential citation
• Correlates of Persistent Endocrine-Disrupting Chemical Mixtures among Reproductive-Aged Black Women.

  2021cites this paper
• The association between prenatal perfluoroalkyl substance exposure and symptoms of attention-deficit/hyperactivity disorder in 8-year-old children and the mediating role of thyroid hormones in the Hokkaido study.

  2021cites this paper
• Structure Database and In Silico Spectral Library for Comprehensive Suspect Screening of Per- and Polyfluoroalkyl Substances (PFASs) in Environmental Media by High-resolution Mass Spectrometry.

  2021cites this paper
• Perfluoroalkyl Substance Exposure and the BDNF Pathway in the Placental Trophoblast

  2021cites this paper
• Comprehensive multi-omics approaches reveal the hepatotoxic mechanism of perfluorohexanoic acid (PFHxA) in mice.

  2021cites this paper
• Enhanced Recovery of Per- and Polyfluoroalkyl Substances (PFASs) from Impacted Soils Using Heat Activated Persulfate.

  2021cites this paper
• Occurrence and distribution of per- and polyfluoroalkyl substances (PFASs) in human livers with liver cancer.

  2021cites this paper
• Associations of single and multiple per- and polyfluoroalkyl substance (PFAS) exposure with vitamin D biomarkers in African American women during pregnancy.

  2021cites this paper